Back to jobs

Senior/Executive Director, Analytical Development

South San Francisco

ABOUT THE COMPANY

Marea Therapeutics is a clinical-stage biotechnology company based in South San Francisco with a growing pipeline of first-in-class therapies to address genetically validated cardioendocrine disease targets. Our therapies have the potential to complement existing therapies and serve as transformative treatment options for significant patient populations living with cardioendocrine diseases. 

Incubated by Third Rock Ventures, Marea completed a Series B financing in June 2024 and is well funded by a syndicate of leading life science investors including Sofinnova, Forbion, Xontogeny/ Perceptive Advisors, venBio, Omega Funds, Surveyor, Alpha Wave and Third Rock Ventures.

The company’s lead program, MAR001, is a monoclonal antibody targeting ANGPTL4, a genetically validated target with potential to address the subset of patients at the highest risk of adverse cardiovascular events, despite current standard of care therapies.   MAR001 is rapidly progressing through Phase 2b clinical development.   Our second clinical asset, MAR002, is a monoclonal antibody targeting excess growth hormone produced by the pituitary gland in the rare hormonal disorder, acromegaly.  MAR002 has potential to become best-in-disease and is rapidly progressing through Phase 1 clinical development.  We also have a third asset that is rapidly advancing through research discovery, with DC nomination expected next year.

At Marea, we believe in the power of collaboration and the importance of leading by example. We are a tight-knit team that values the contributions of every member, from interns to senior leaders. Our environment is dynamic, with each day presenting new challenges and opportunities for growth. Every role is “Hands-On”, and the successful candidate will be able to work alongside team members, regardless of level, to understand challenges and drive results. 

ABOUT THE ROLE

The Senior/Executive Director of Analytical Development will be both the strategic head and technical driver of analytical development across Marea’s pipeline. This individual will set the vision for analytical sciences while also remaining engaged in the detailed design, execution, and troubleshooting of methods.  This is a key role Technical Operations team as we aggressively advance the first program towards late-stage development and our second program into early-stage clinical development.  This role will initially report to the CTO.  The successful candidate will be a working leader: equally comfortable shaping analytical strategy suitable for major submissions, presenting to authorities, and at the same time being hands-on reviewing data packages, troubleshooting methods with the team and partners. The successful candidate will have strong technical background in developing, qualifying and transferring necessary in-process, release and characterization methods to support development of all monoclonal antibody programs at Marea. The candidate will work closely with other members of the technical operations team including process development, manufacturing, QC and QA, and CMC regulatory as well as cross-functionally with research and clinical team to support the larger program goals.  Ideal candidate will offer a mix of strong technical skills in monoclonal antibody in method development, hands-on laboratory development experience, experience working with CDMOs and CTLs and ability to develop strong written technical data packages that are phase appropriate and of high quality expected in regulatory submissions.  Candidate needs to have demonstrated experience or minimally basic familiarity in various physicochemical methods (chromatographic, electrophoretic, peptide mapping), biochemical assays, functional assays, impurity and residual testing, stability and degradation studies to support the overall product release, process control, product characterization, process improvements, comparability assessments and regulatory submissions.  Familiarity or experience in bioassay development will be very desirable.  Ideal candidate will have primary experience in multiple molecular modalities with primary focus on monoclonal antibodies as wells as siRNA lipid conjugate based drugs.  Solid understanding of the necessary ICH and USP regulations and experience supporting regulatory submissions at various development stages is critical.  We expect this role will evolve in scope and complexity as the programs advance to later stages of development.

This is a full-time, South San Francisco-based position with the expectation of working on-site at least three days per week.

KEY RESPONSIBILITIES

  • Lead and implement the overall analytical development plan for the portfolio assets that encompass in-process controls, product release, characterization, comparability, impurity and residual testing, stability and degradation, physicochemical and biochemical characterization methods. Candidate is expected to work with external CDMOs and CTLs to find the most efficient and scientifically sound plan and implement it for manufacturing at the CDMOs.
  • Oversee development and phase appropriate qualification or validation of analytical methods for release, stability, comparability and in-process testing.
  • Collaborate cross functionally with process development, QA/QC, Regulatory CMC to support IND filings, BLAs and other regulatory documents.
  • Guide method transfer and troubleshooting at contract testing labs and CDMOs.
  • Personally engage in data review and method optimization for complex physicochemical and bioassay methods
  • Lead characterization studies to support structural elucidation, product profile variant assays (size, charge glycosylation) and in the future binding assays
  • Develop phase appropriate control and release strategy, specifications to support GMP manufacturing of drug substance and drug product
  • Provide necessary technical oversight of the development and QC activities at the CDMO/CTLs
  • Ensure compliance with ICH, cGMP and regulatory requirements
  • Develop comparability strategy and plans in support of process and product life cycle changes and also in support of clinical development plans.
  • Plan and prioritize resources across programs in a lean, dynamic environment.
  • Help establish Marea’s long-term analytical infrastructure, balancing external outsourcing with selective in-house build-out.

 
QUALIFICATIONS 

  • PhD in Analytical Chemistry, Biochemistry or related discipline with 12+ years of relevant experience (Senior Director level) or 15+ years of experience (Executive Director level) in biologics drug development focused on analytical development. The level of the role is flexible between Senior and Executive Director based on years and totality of experience.
  • Expertise in key analytical methods for development of monoclonal antibody drugs, including: HPLC/UPLC (SEC, IEC, RP), CE-SDS, IEF, mass spectrometry (intact and peptide mapping), ELISA, cell-based assays, binding kinetics
  • Experience with cell-based assays is desirable
  • Proven experience in authoring content for regulatory submissions and preferably interacting with health authorities
  • Experience working with CDMOs and contract testing labs
  • Hands-on experience troubleshooting and optimizing complex analytical methods; ability to dive deep into technical data when needed.
  • Track record of supporting programs through IND, late-stage development, and BLA, including direct regulatory interactions.
  • Strong leadership skills specifically working cross-functionally with internal team and with external partners
  • Exceptional ability to flex between strategic planning and hands-on execution in a lean, start-up environment.


PAY RANGE

The salary range for this role is $250,000 - $295,000. Compensation and title will be competitive and commensurate with the candidate's experience, qualifications, and the responsibilities of the position.


WORKING CONDITION

  • The role may need to occasionally work in laboratory environment.
  • Travel to CDMOs/CTLs may be needed up to 10% of the time (variable, with some peak windows)

 

#LI-Hybrid

 

We do not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity or expression, national origin, age, disability, veteran status, marital status, or based on an individual’s status in any group or class protected by applicable federal, state, and local law. We invite applications from minorities, women, the disabled, protected veterans, and all other qualified applicants. 

Create a Job Alert

Interested in building your career at Marea Therapeutics? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Phone
Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf


Education

Select...
Select...
Select...

Select...
Select...

U.S. Standard Demographic Questions

We invite applicants to share their demographic background. If you choose to complete this survey, your responses may be used to identify areas of improvement in our hiring process.
Select...
Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Marea Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.